NCT02477306 - A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Healthy

Interventions

DRUG

Idiazole 20mg DR tabs

Delayed release tablets containing 20 mg of rabeprazole

DRUG

PARIET 20 mg DR tabs

Orally administered, delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium.

Trial Locations (1)

Genuine Research Center GRC, Cairo